Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia-Reference-Cited by-同舟云学术

Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia

Published:2009-12 Issue: Volume:15 Page:S59-S63
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Cenci M. Angela,Ohlin K. Elisabet,Rylander Daniella

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference43 articles.

1. Risk factors for levodopa-induced dyskinesias in Parkinson's disease;Grandas;J Neurol,1999

2. Levodopa-induced dyskinesias, the clinical problem: clinical features, incidence, risk factors, management and impact on quality of life;Manson,2006

3. New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity;Linazasoro;Trends Pharmacol Sci,2005

4. Postversus presynaptic plasticity in L-DOPA-induced dyskinesia;Cenci;J Neurochem,2006

5. BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease;Foltynie;J Neurol Neurosurg Psychiatry,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling differential gene co-expression networks and its effects on levodopa-induced dyskinesia;iScience;2024-09

2. Construct, Face, and Predictive Validity of Parkinson’s Disease Rodent Models;International Journal of Molecular Sciences;2024-08-17

3. Impaired cognitive and motor function are coincident with l-DOPA-induced dyskinesia in a model of Parkinson’s disease;Scientific Reports;2023-10-17

4. MSC-Derived Exosomes can Enhance the Angiogenesis of Human Brain MECs and Show Therapeutic Potential in a Mouse Model of Parkinson's Disease;Aging and disease;2021

5. Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?;Neurotoxicity Research;2020-11-03